Horizon Therapeutics (F/K/A) Horizon Pharma USA INC
Biopharmaceutical company
Based in IL
AI Overview
With $1.4M in lobbying spend across 25 quarterly filings, Horizon Therapeutics (F/K/A) Horizon Pharma USA INC is a significant lobbying presence. Their lobbying covers 3 issue areas. Active from 2018 to 2023.
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2018 | $330K |
| 2019 | $240K |
| 2020 | $220K |
| 2021 | $180K |
| 2022 | $160K |
| 2023 | $300K |
Issues Lobbied
Lobbying Firms
Lobbyists
Government Agencies Targeted
These are the government entities that Horizon Therapeutics (F/K/A) Horizon Pharma USA INC disclosed contacting in their lobbying filings.
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Taxation, Pharmacy, Medicare/Medicaid
Tax Reform, generally; HR 1, An Act to provide for reconciliation pursuant to titles II and V of the concurrent resolution on the budget for fiscal year 2018 (Tax Cuts and Jobs Act).
340B Refprm; drug pricing and general pharmaceutical issues; 340B definition of "Patient;"
Executive order on Drug Pricing
340B Reform; drug pricing and general pharmaceutical issues; 340B definition of "Patient;"
Executive order on Drug Pricing; Administration Prescription Drug Policy.
Related Analysis
Related Investigations
Similar Clients
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.